Literature DB >> 12646724

Functional analysis of a rare HBV deletion mutant in chronically infected children.

Patrick Gerner1, Heike Marie Clara Schäfer, Reinhild Prange, Dirk Pravitt, Stefan Wirth.   

Abstract

Liver damage caused by chronic hepatitis B virus (HBV) infection may be enhanced through the selection of deleted HBV preS mutants by intracellular accumulation of viral proteins and subsequent cell death. However, the prevalence and impact of such mutants on the clinical course of infection have not yet been studied in children. Serum samples from 60 children (mean age 9.8 y) were investigated by means of PCR and direct sequencing of the entire preS region. Only one patient (1.5%) was found with a mixed HBV population of a deletion spanning 183 nucleotides and wild-type sequences. This mutation alters the HBV large-surface protein and removes the small-surface promoter. To clarify the significance of this mutation, we studied 14 serial serum samples of the child within a follow-up of 10 y. After occurrence of the mutation, the liver enzymes increased, despite seroconversion to anti-HBe. Transfection of an HBV expression construct containing this deletion into human hepatoma cells by using an HBV in vitro replication system showed that the mutant lost the ability of nucleocapsid packaging as a result of alteration of the transmembrane topology of the large surface protein. This effect could not be restored by coexpression of wild-type large- or small-surface proteins in trans. In conclusion, the circulation of HBV preS deletion mutants is rare in childhood. However, our functional and clinical follow-up studies in one child suggest that such a mutant may have the potential to aggravate liver inflammation, especially if corroborated with larger numbers of children.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646724     DOI: 10.1203/01.PDR.0000064906.63939.72

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  5 in total

1.  Hepatitis B virus subgenotype A1 predominates in liver disease patients from Kerala, India.

Authors:  Deepak Gopalakrishnan; Mark Keyter; Kotacherry Trivikrama Shenoy; Kondarappassery Balakumaran Leena; Lakshmikanthan Thayumanavan; Varghese Thomas; Kr Vinayakumar; Charles Panackel; Arun T Korah; Ramesh Nair; Anna Kramvis
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

2.  Novel recombinant hepatitis B virus vectors efficiently deliver protein and RNA encoding genes into primary hepatocytes.

Authors:  Ran Hong; Weiya Bai; Jianwei Zhai; Wei Liu; Xinyan Li; Jiming Zhang; Xiaoxian Cui; Xue Zhao; Xiaoli Ye; Qiang Deng; Pierre Tiollais; Yumei Wen; Jing Liu; Youhua Xie
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

Review 3.  Spacer Domain in Hepatitis B Virus Polymerase: Plugging a Hole or Performing a Role?

Authors:  Caitlin Pley; José Lourenço; Anna L McNaughton; Philippa C Matthews
Journal:  J Virol       Date:  2022-04-12       Impact factor: 6.549

Review 4.  Hepatitis B virus pre-S/S variants in liver diseases.

Authors:  Bing-Fang Chen
Journal:  World J Gastroenterol       Date:  2018-04-14       Impact factor: 5.742

5.  Different pre-S deletion patterns and their association with hepatitis B virus genotypes.

Authors:  Bing-Fang Chen
Journal:  World J Gastroenterol       Date:  2016-09-21       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.